COVID-19-Related HCQ Shortages Affected Rheum Patients Worldwide COVID-19-Related HCQ Shortages Affected Rheum Patients Worldwide

Supplies were diverted for COVID when hydroxychloroquine was hyped, without good evidence, as a treatment. In some parts of the world more than 1 in 4 with autoimmune diseases could not get medicines.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Rheumatology News Source Type: news